Employers

As the coronavirus disease 2019 pandemic causes employers nationwide to implement strategies to efficiently operate amid potential revenue loss, the National Alliance of Healthcare Purchaser Coalitions released a comprehensive plan for employers and plan sponsors to optimize the delivery of advanced primary care.

Anti-anxiety and anti-insomnia prescriptions surged after mid-March after the coronavirus disease 2019 (COVID) pandemic was declared, said Glen Stettin, senior vice president and chief innovation officer at Express Scripts, who discussed the use of mental health and behavioral health prescriptions during the current public health emergency.

According to the most recent PwC Health Research Institute Consumer Survey results, the top consumer concerns for the post–coronavirus disease 2019 (COVID-19) period are overall health and financial well-being, with 32% saying health-related spending adjustments have already occurred or are in the planning stages.

As some states move to eschew social distancing recommendations by beginning plans to reopen businesses amid the coronavirus disease 2019 pandemic, a group of economists highlight in a recent study that the potential benefits of social distancing in saving lives far outweigh the projected damage to the economy.

Nearly 7 in 10 employees indicated in a survey by mental health provider Ginger that the coronavirus disease 2019 (COVID-19) pandemic is the most stressful time of their entire professional career, which has aligned with stark increases in new prescriptions of antidepressant, antianxiety, and anti-insomnia medications.

In the second part of a 2-part preview interview in advance of this year’s virtual 2020 Community Oncology Conference, The American Journal of Managed Care® speaks with Cheryl Larson, president and chief executive officer of the Midwest Business Group on Health, about how she is helping employer organizations navigate their pharmacy benefits managers and manage employee expectations.

In the first part of a 2-part preview interview in advance of this year’s virtual 2020 Community Oncology Conference, The American Journal of Managed Care® speaks with Cheryl Larson, president and chief executive officer of the Midwest Business Group on Health, about how she is helping employer organizations navigate their pharmacy benefits managers and manage employee expectations.

As the coronavirus disease 2019 (COVID-19) pandemic exposes and exacerbates social determinants of health (SDOH) in at-risk communities, services such as clinical trials and personalized care can prove effective interventions for employers in providing access to vital health services.

Amid the coronavirus disease 2019 pandemic, the use of telemedicine has expanded among employers and healthcare providers to ensure effective coverage without risking potential exposure.

Centivo has launched a new health plan solution, aimed at lowering costs for employees; trial results show dead bacteria may be effective in treating IBS; continuous glucose monitoring systems are now being used in hospitalized patients with diabetes and coronavirus disease 2019 (COVID-19).

As part of the National Alliance of Healthcare Purchaser Coalitions Employer Town Hall series on the coronavirus disease 2019 (COVID-19), speakers discussed how employers are helping employees and their families to maintain mental health and wellness, with additional input on those managing existing mental health conditions.

In a study released Monday by the Integrated Benefits Institute, researchers found that due to lost time from work caused by the novel coronavirus disease 2019 (COVID-19), employee benefits for absent workers could cost employers more than $23 billion.

Employers are showing great interest in value-based insurance design, as they recognize their role in shaping how their employees’ share of healthcare costs can affect what care they seek.

In a survey released this week, half of US small business owners said they cannot afford to pay employees for a full month amid the economic lockdown caused by coronavirus disease 2019, with 1 in 5 also noting their inability to afford wages for a week or less.

The coronavirus disease 2019 (COVID-19) pandemic has led to healthcare cost increases of as much as 7% for employers, based on recent study results, stressing the essential need for organizations to have a plan that supports employees and potential revenue loss.

During the coronavirus disease 2019 (COVID-19) pandemic, Innovaccer’s free to use COVID-19 Management System promotes the ability for patients to implement self-assessments to determine severity risk, which could prove crucial in at-risk, under resourced populations.